GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a history of widespread use in food. This designation plays a critical role in ensuring the safety of foods and dietary ingredients, including probiotic strains.
L. rhamnosus CA15 was granted GRAS (Generally Recognized as Safe) status, based on expert consensus and a thorough review of scientific evidence, ensuring high safety standards and guaranteeing regulatory compliance, which is crucial for consumer trust and industry credibility.
L. rhamnosus CA15 has been shown to be particularly effective in restoring vaginal health. It works by normalizing physiological pH, exhibiting strong antibacterial activity, and promoting the dominance of lactobacilli within the vaginal microbiota. Clinical studies have demonstrated that this strain can alleviate symptoms of vaginal discomfort and significantly improve the quality of life for women. Remarkably, the benefits of a just 10-day oral treatment with CA15 can persist for up to 30 days after the treatment ends.
Before being involved in clinical studies, CA15 underwent a rigorous selection process and thorough characterization, establishing it as an ideal probiotic candidate for women’s health. The strain has been found to antagonize a broad spectrum of pathogens, adhere to both vaginal and intestinal cell lines, and exhibit anti-inflammatory and antioxidant activities. These properties suggest that CA15 could be useful in preventing and treating gastrointestinal issues, supporting immune function, and enhancing overall gut health.
Achieving GRAS status is a crucial step in ensuring consumer safety and confidence in the product. This recognition will help expand the presence of CA15 in the US market, supporting the health and well-being of many women. As the demand for probiotics in functional foods and dietary supplements continues to grow, L. rhamnosus CA15 stands out as a trusted choice for consumers and industry stakeholders alike.
The GRAS status not only underscores the safety and efficacy of CA15 but also opens new opportunities for its application in various wellness products. With its proven benefits and regulatory approval, CA15 is poised to make a significant impact on women’s well-being. It offers a natural and effective solution for maintaining vaginal health and overall well-being. This probiotic strain promises to support women in their daily routine, enhancing their quality of life through its comprehensive benefits.